Replies to post #360011 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

It should be no surprise that the dropouts in the Biogen trials did not rollover into the OLE just as the figures you quote supports.

How many dropouts were there in the Anavex AD P2b/3 trial?

Given any other potential inclusion/exclusion criteria, is a 90% or so OLE rollover rate uncommon in a CNS trial?

Is that standalone 90% figure a useful indication of how effective A2-73 was?

How effective did the placebo cohort patients feel A2-73 was for them? Apparently they must have felt it was quite good with such a high OLE rollover rate.

[rayovacAAA]

MISSLING HAS BEEN RECEIVING REAL TIME A2-73 P2B/3 AD TRIAL DATA THROUGH EHRS OVER SECURE 5G DATA NET WORKS!!!!!!!!

I bet our drop out rate is low compared to them and I bet our OLE rate crushes them as well. Anyone have this data?

MISSLING HAS THIS DATA AND HE IS CURRENTLY SMILING LIKE THE CAT WHO ATE THE CANARY!!!!!!!!


WGT!!!!!!!!